Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Blueprint Medicines discloses neurotrophic tyrosine kinase receptors inhibitors

June 13, 2017

Genentech and Roche identify JAK inhibitors

June 13, 2017

Roche discovers cathepsin S inhibitors

June 13, 2017

Medshine Discovery patents IL-6 release inhibitors

June 13, 2017

Sunshine Lake Pharma discloses orexin OX1 and OX2 receptor antagonists

June 13, 2017

Lyvgen Biopharma Holdings presents anti-PD-1 antibodies

June 12, 2017

University of Georgia and ArunA Biomedical patent neural cell extracellular vesicles

June 12, 2017

Pfizer presents immunogenic compositions for use in pneumococcal vaccines

June 12, 2017

MRC Technology identifies MAP kinase-interacting serine/threonine-protein kinase 1 inhibitors

June 12, 2017

RQx Pharmaceuticals and Genentech divulge bacterial spsB inhibitors

June 12, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...